These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8957436)

  • 1. Extracorporeal circulation, hemocompatibility, and biomaterials.
    Janvier G; Baquey C; Roth C; Benillan N; Bélisle S; Hardy JF
    Ann Thorac Surg; 1996 Dec; 62(6):1926-34. PubMed ID: 8957436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mini extracorporeal circuit cardiopulmonary bypass system: a review.
    Curtis N; Vohra HA; Ohri SK
    Perfusion; 2010 May; 25(3):115-24. PubMed ID: 20581025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-coated cardiopulmonary bypass circuits.
    Gravlee GP
    J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):213-22. PubMed ID: 8204814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The "benefits" of the mini-extracorporeal circulation in the minimal invasive cardiac surgery era.
    Baikoussis NG; Papakonstantinou NA; Apostolakis E
    J Cardiol; 2014 Jun; 63(6):391-6. PubMed ID: 24629908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMART tubing presents an increased risk of disconnection during extracorporeal circulation.
    Newling R; Morris R
    J Extra Corpor Technol; 2005 Dec; 37(4):400-1. PubMed ID: 16524161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Issues of biocompatibility: heparin-coated extracorporeal circuit.
    Hsu LC
    Int Anesthesiol Clin; 1996; 34(2):109-22. PubMed ID: 8799749
    [No Abstract]   [Full Text] [Related]  

  • 9. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
    Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
    J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation management associated with extracorporeal circulation.
    Sniecinski RM; Levy JH
    Best Pract Res Clin Anaesthesiol; 2015 Jun; 29(2):189-202. PubMed ID: 26060030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypass.
    Weerwind PW; Maessen JG; van Tits LJ; Stad RK; Fransen EJ; de Jong DS; Penn OC
    J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1633-41. PubMed ID: 8523873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombogenicity is not reduced when heparin and phospholipid bonded circuits are used in a rabbit model of extracorporeal circulation.
    Meinhardt JP; Annich GM; Miskulin J; Kawai T; Ashton BA; Bartlett RH
    ASAIO J; 2003; 49(4):395-400. PubMed ID: 12918580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocompatibility in cardiopulmonary bypass.
    Hsu LC
    J Cardiothorac Vasc Anesth; 1997 May; 11(3):376-82. PubMed ID: 9161907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coating of extracorporeal circuit with heparin does not prevent sequestration of propofol in vitro.
    Hammarén E; Rosenberg PH; Hynynen M
    Br J Anaesth; 1999 Jan; 82(1):38-40. PubMed ID: 10325833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance.
    Ovrum E; Am Holen E; Tangen G; Ringdal MA
    Ann Thorac Surg; 1996 Oct; 62(4):1128-33. PubMed ID: 8823101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers.
    Annich GM; Meinhardt JP; Mowery KA; Ashton BA; Merz SI; Hirschl RB; Meyerhoff ME; Bartlett RH
    Crit Care Med; 2000 Apr; 28(4):915-20. PubMed ID: 10809259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface modification of extracorporeal circuits: is there really an impact on cerebral performance after cardiopulmonary bypass?
    Isgro F; Kiessling AH; Mittelstaedt H; Saggau W
    Thorac Cardiovasc Surg; 2001 Apr; 49(2):65-9. PubMed ID: 11339453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation.
    Wendel HP; Ziemer G
    Eur J Cardiothorac Surg; 1999 Sep; 16(3):342-50. PubMed ID: 10554855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility of extracorporeal circuits in heart surgery.
    van Oeveren W; Wildevuur CR; Kazatchkine MD
    Transfus Sci; 1990; 11(1):5-33. PubMed ID: 10171165
    [No Abstract]   [Full Text] [Related]  

  • 20. Biocompatibility reflected by haemostasis variables during cardiopulmonary bypass using heparin-coated circuits.
    Borowiec J; Bagge L; Saldeen T; Thelin S
    Thorac Cardiovasc Surg; 1997 Aug; 45(4):163-7. PubMed ID: 9323816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.